Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

774.61
+0.50000.06%
Post-market: 774.610.00000.00%16:15 EDT
Volume:379.66K
Turnover:294.50M
Market Cap:79.75B
PE:19.16
High:779.98
Open:775.82
Low:771.80
Close:774.11
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.70
T/O Rate:0.38%
Dividend:3.64
Dividend Rate:0.47%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.51
PE(LYR):18.67

Loading ...

Regeneron (REGN) Receives a Buy from Goldman Sachs

TIPRANKS
·
Jul 22

Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Regeneron (REGN)

TIPRANKS
·
Jul 22

Regeneron’s POTS Study Wraps Up: What REGN7544 Could Mean for REGN Investors

TIPRANKS
·
Jul 22

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785

MT Newswires Live
·
Jul 22

Regeneron Pharma is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 21

Telix Expects Fy2026 Revenue and Other Income Above US$1 Billion, Tracks Upper End of Guidance Range

Reuters
·
Jul 21

Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $965 From $968, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Biohaven enters into clinical supply agreement with Regeneron

TIPRANKS
·
Jul 20

Biohaven Signs Regeneron Supply Deal to Test Bhv-1530 with Libtayo

Reuters
·
Jul 20

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

Reuters
·
Jul 16

Movement Alert|Regeneron Pharmaceuticals Falls 3.2% in Pre-Market Trading, Multiple Banks Cut Target Prices Amid Q2 Earnings Warning

Market Focus
·
Jul 16

Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings

Dow Jones
·
Jul 16

Regeneron’s dupilumab granted orphan drug designation

TIPRANKS
·
Jul 15

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

These Biggest and "Least Loved" Stocks Are the Ones to Pick Ahead of Earnings

Dow Jones
·
Jul 13

Regeneron price target lowered to $854 from $855 at Piper Sandler

TIPRANKS
·
Jul 09

Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855

MT Newswires Live
·
Jul 09

Regeneron Pharma is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 09

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires Live
·
Jul 08

Regeneron price target lowered to $730 from $788 at Morgan Stanley

TIPRANKS
·
Jul 08